{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T20:49:19Z","timestamp":1790196559858,"version":"4.1.0"},"reference-count":64,"publisher":"Deutscher Arzte-Verlag GmbH","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.3238\/arztebl.2017.0197","type":"journal-article","created":{"date-parts":[[2018,5,2]],"date-time":"2018-05-02T09:29:13Z","timestamp":1525253353000},"source":"Crossref","is-referenced-by-count":26,"title":["Cardiovascular Comorbidity in Inflammatory Rheumatological Conditions"],"prefix":"10.3238","author":[{"given":"J\u00fcrgen","family":"Braun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Kr\u00fcger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard","family":"Manger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christof","family":"Specker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans Joachim","family":"Trappe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"11437","published-online":{"date-parts":[[2017,3,24]]},"reference":[{"key":"10.3238\/arztebl.2017.0197_ref1","doi-asserted-by":"crossref","unstructured":"Corrao S, Messina S, Pistone G, Calvo L, Scaglione R, Licata G: Heart involvement in rheumatoid arthritis: systematic review and meta-analysis. Int J Cardiol 2013; 167: 2031\u20138","DOI":"10.1016\/j.ijcard.2012.05.057"},{"key":"10.3238\/arztebl.2017.0197_ref2","doi-asserted-by":"crossref","unstructured":"Turesson C: Extraarticular rheumatoid arthritis. Curr Opin Rheumatol 2013; 25: 360\u20136","DOI":"10.1097\/BOR.0b013e32835f693f"},{"key":"10.3238\/arztebl.2017.0197_ref3","doi-asserted-by":"crossref","unstructured":"Kr\u00fcger K: Therapie kardialer Risikofaktoren. Z Rheumatol 2016; 75: 173\u201382","DOI":"10.1007\/s00393-016-0064-8"},{"key":"10.3238\/arztebl.2017.0197_ref4","doi-asserted-by":"crossref","unstructured":"Nurmohamed MT, Heslinga M, Kitas GD: Cardiovascular comorbidity in rheumatic diseases. Nat Rev Rheumatol 2015; 11: 693\u2013704","DOI":"10.1038\/nrrheum.2015.112"},{"key":"10.3238\/arztebl.2017.0197_ref5","doi-asserted-by":"crossref","unstructured":"Avina-Zubieta JA, Choi HK, Sadatsafavi M, et al.: Risk of cardiovascular mortality in patients with rheumatoid arthritis: a metaanalysis of observational studies. Arthritis Rheum 2008; 59: 1690\u20137","DOI":"10.1002\/art.24092"},{"key":"10.3238\/arztebl.2017.0197_ref6","doi-asserted-by":"crossref","unstructured":"Sparks JA, Chang SC, Liao KP, et al.: Rheumatoid arthritis and mortality among women during 36 years of prospective follow-up: Results from the Nurses\u2019 Health Study. Arthritis Care Res (Hoboken) 2016; 68: 753\u201362","DOI":"10.1002\/acr.22752"},{"key":"10.3238\/arztebl.2017.0197_ref7","doi-asserted-by":"crossref","unstructured":"Roubille C, Richter V, Starnino T, et al.: The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis. Ann Rheum Dis 2015; 74: 480\u20139","DOI":"10.1136\/annrheumdis-2014-206624"},{"key":"10.3238\/arztebl.2017.0197_ref8","doi-asserted-by":"crossref","unstructured":"Solomon DH, Liu CC, Kuo IH, Zak A, Kim SC: Effects of colchicine on risk of cardiovascular events and mortality among patients with gout: a cohort study using electronic medical records linked with Medicare claims. Ann Rheum Dis 2016; 75: 1674\u20139","DOI":"10.1136\/annrheumdis-2015-207984"},{"key":"10.3238\/arztebl.2017.0197_ref9","doi-asserted-by":"crossref","unstructured":"Zink A, Albrecht K: How frequent are musculoskeletal diseases in Germany? Z Rheumatol 2016; 75: 346\u201353","DOI":"10.1007\/s00393-016-0094-2"},{"key":"10.3238\/arztebl.2017.0197_ref10","doi-asserted-by":"crossref","unstructured":"Kelly CA, Saravanan V, Nisar M, et al.: Rheumatoid arthritis-related interstitial lung disease: associations, prognostic factors and physiological and radiological characteristics\u2014a large multicentre UK study. Rheumatology (Oxford) 2014; 53: 1676\u201382","DOI":"10.1093\/rheumatology\/keu165"},{"key":"10.3238\/arztebl.2017.0197_ref11","doi-asserted-by":"crossref","unstructured":"Kobayashi Y, Giles JT, Hirano M, et al.: Assessment of myocardial abnormalities in rheumatoid arthritis using a comprehensive cardiac magnetic resonance approach: a pilot study. Arthritis Res Ther 2010; 12: R171","DOI":"10.1186\/ar3131"},{"key":"10.3238\/arztebl.2017.0197_ref12","doi-asserted-by":"crossref","unstructured":"Myasoedova E, Crowson CS, Nicola PJ, et al.: The influence of rheumatoid arthritis disease characteristics on heart failure. J Rheumatol 2011; 38: 1601\u20136","DOI":"10.3899\/jrheum.100979"},{"key":"10.3238\/arztebl.2017.0197_ref13","doi-asserted-by":"crossref","unstructured":"Crowson CS, Nicola PJ, Kremers HM, et al.: How much of the increased incidence of heart failure in rheumatoid arthritis is attributable to traditional cardiovascular risk factors and ischemic heart disease? Arthritis Rheum 2005; 52: 3039\u201344","DOI":"10.1002\/art.21349"},{"key":"10.3238\/arztebl.2017.0197_ref14","doi-asserted-by":"crossref","unstructured":"Kim SC, Liu J, Solomon DH: The risk of atrial fibrillation in patients with rheumatoid arthritis. Ann Rheum Dis 2014; 73: 1091\u20135","DOI":"10.1136\/annrheumdis-2013-203343"},{"key":"10.3238\/arztebl.2017.0197_ref15","doi-asserted-by":"crossref","unstructured":"Braun J, Sieper J: Ankylosing spondylitis. Lancet 2007; 369: 1379\u201390","DOI":"10.1016\/S0140-6736(07)60635-7"},{"key":"10.3238\/arztebl.2017.0197_ref16","unstructured":"Lautermann D, Braun J: Ankylosing spondylitis\u2014cardiac manifestations. Clin Exp Rheumatol 2002; 20 (6 Suppl 28): S11\u20135"},{"key":"10.3238\/arztebl.2017.0197_ref17","doi-asserted-by":"crossref","unstructured":"Bakland G, Gran JT, Nossent JC: Increased mortality in ankylosing spondylitis is related to disease activity. Ann Rheum Dis 2011; 70: 1921\u20135","DOI":"10.1136\/ard.2011.151191"},{"key":"10.3238\/arztebl.2017.0197_ref18","doi-asserted-by":"crossref","unstructured":"Roldan CA, Chavez J, Wiest PW, Qualls CR, Crawford MH: Aortic root disease and valve disease associated with ankylosing spondylitis. J Am Coll Cardiol 1998; 32: 1397\u2013404","DOI":"10.1016\/S0735-1097(98)00393-3"},{"key":"10.3238\/arztebl.2017.0197_ref19","doi-asserted-by":"crossref","unstructured":"Bergfeldt L, Edhag O, Vedin L, Vallin H: Ankylosing spondylitis: an important cause of severe disturbances of the cardiac conduction system. Prevalence among 223 pacemaker-treated men. Am J Med 1982; 73: 187\u201391","DOI":"10.1016\/0002-9343(82)90177-2"},{"key":"10.3238\/arztebl.2017.0197_ref20","doi-asserted-by":"crossref","unstructured":"Bergfeldt L, Insulander P, Lindblom D, Moller E, Edhag O: HLA-B27: an important genetic risk factor for lone aortic regurgitation and severe conduction system abnormalities. Am J Med 1988; 85: 12\u20138","DOI":"10.1016\/0002-9343(88)90497-4"},{"key":"10.3238\/arztebl.2017.0197_ref21","doi-asserted-by":"crossref","unstructured":"Bulkley BH, Roberts WC: Ankylosing spondylitis and aortic regurgitation. Description of the characteristic cardiovascular lesion from study of eight necropsy patients. Circulation 1973; 48: 1014\u201327","DOI":"10.1161\/01.CIR.48.5.1014"},{"key":"10.3238\/arztebl.2017.0197_ref22","doi-asserted-by":"crossref","unstructured":"van der Helm-van Mil AH: Acute rheumatic fever and poststreptococcal reactive arthritis reconsidered. Curr Opin Rheumatol 2010; 22: 437\u201342","DOI":"10.1097\/BOR.0b013e328337ba26"},{"key":"10.3238\/arztebl.2017.0197_ref23","doi-asserted-by":"crossref","unstructured":"Aminoshariae A, Kulild JC, Donaldson M: Short-term use of nonsteroidal anti-inflammatory drugs and adverse effects: An updated systematic review. J Am Dent Assoc 2016; 147: 98\u2013110","DOI":"10.1016\/j.adaj.2015.07.020"},{"key":"10.3238\/arztebl.2017.0197_ref24","doi-asserted-by":"crossref","unstructured":"Kroon FP, van der Burg LRA, Ramiro S, et al.: Non-steroidal anti-inflammatory drugs (NSAIDs) for axial spondyloarthritis (ankylosing spondylitis and non-radiographic axial spondyloarthritis). Cochrane Database Syst Rev 2015; 17: CD010952","DOI":"10.1002\/14651858.CD010952.pub2"},{"key":"10.3238\/arztebl.2017.0197_ref25","doi-asserted-by":"crossref","unstructured":"Haroon NN, Paterson JM, Li P, Inman RD, Haroon N: patients with ankylosing spondylitis have increased cardiovascular and cerebrovascular mortality: a population-based study. Ann Intern Med 2015; 163: 409\u201316","DOI":"10.7326\/M14-2470"},{"key":"10.3238\/arztebl.2017.0197_ref26","doi-asserted-by":"crossref","unstructured":"Mavrogeni S, Dimitroulas T, Kitas GD: Multimodality imaging and the emerging role of cardiac magnetic resonance in autoimmune myocarditis. Autoimmun Rev 2012; 12: 305\u201312","DOI":"10.1016\/j.autrev.2012.05.005"},{"key":"10.3238\/arztebl.2017.0197_ref27","doi-asserted-by":"crossref","unstructured":"Ferri C, Valentini G, Cozzi F, et al.: Systemic Sclerosis Study Group of the Italian Society of Rheumatology (SIR-GSSSc). Systemic sclerosis: Demographic, clinical, and serologic features and survival in 1,012 Italian patients. Medicine (Baltimore) 2002; 81: 139\u201353","DOI":"10.1097\/00005792-200203000-00004"},{"key":"10.3238\/arztebl.2017.0197_ref28","doi-asserted-by":"crossref","unstructured":"Pagnoux C, Guillevin L: Cardiac involvement in small and medium-sized vessel vasculitides. Lupus 2005; 14: 718\u201322","DOI":"10.1191\/0961203305lu2207oa"},{"key":"10.3238\/arztebl.2017.0197_ref29","doi-asserted-by":"crossref","unstructured":"Ogdie A, Yu Y, Haynes K, et al.: Risk of major cardiovascular events in patients with psoriatic arthritis, psoriasis and rheumatoid arthritis: apopulation-based cohort study. Ann Rheum Dis 2015; 74: 326\u201332","DOI":"10.1136\/annrheumdis-2014-205675"},{"key":"10.3238\/arztebl.2017.0197_ref30","doi-asserted-by":"crossref","unstructured":"Houri Levi E, Watad A, Whitby A, et al.: Coexistence of ischemic heart disease and rheumatoid arthritis patients\u2014a case control study. Autoimmun Rev 2016; 15: 393\u20136","DOI":"10.1016\/j.autrev.2016.01.006"},{"key":"10.3238\/arztebl.2017.0197_ref31","doi-asserted-by":"crossref","unstructured":"Chung CP, Giles JT, Petri M, et al.: Prevalence of traditional modifiable cardiovascular risk factors in patients with rheumatoid arthritis: Comparison with control subjects from the multi-ethnic study of atherosclerosis. Semin Arthritis Rheum 2012; 41: 535\u201344","DOI":"10.1016\/j.semarthrit.2011.07.004"},{"key":"10.3238\/arztebl.2017.0197_ref32","doi-asserted-by":"crossref","unstructured":"Essers I, Stolwijk C, Boonen A, et al.: Ankylosing spondylitis and risk of ischaemic heart disease: a population-based cohort study. Ann Rheum Dis 2016; 75: 203\u20139","DOI":"10.1136\/annrheumdis-2014-206147"},{"key":"10.3238\/arztebl.2017.0197_ref33","doi-asserted-by":"crossref","unstructured":"Szabo SM, Levy AR, Rao SR, et al.: Increased risk of cardiovascular and cerebrovascular diseases in individuals with ankylosing spondylitis: a population-based study. Arthritis Rheum 2011; 63: 3294\u2013304","DOI":"10.1002\/art.30581"},{"key":"10.3238\/arztebl.2017.0197_ref34","doi-asserted-by":"crossref","unstructured":"Manger K, Kusus M, Forster C, et al.: Factors associated with coronary artery calcification in young female patients with SLE. Ann Rheum Dis 2003; 62: 846\u201350","DOI":"10.1136\/ard.62.9.846"},{"key":"10.3238\/arztebl.2017.0197_ref35","doi-asserted-by":"crossref","unstructured":"Lin K, Lloyd-Jones DM, Li D, et al.: Imaging of cardiovascular complications in patients with systemic lupus erythematosus. Lupus 2015; 24: 1126\u201334","DOI":"10.1177\/0961203315588577"},{"key":"10.3238\/arztebl.2017.0197_ref36","doi-asserted-by":"crossref","unstructured":"Agca R, Heslinga SC, Rollefstad S, et al.: EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015\/2016 update. Ann Rheum Dis 2017; 76: 17\u201328","DOI":"10.1136\/annrheumdis-2016-209775"},{"key":"10.3238\/arztebl.2017.0197_ref37","doi-asserted-by":"crossref","unstructured":"Duru N, van der Goes MC, Jacobs JW, et al.: EULAR evidence-based and consensus-based recommendations on the management of medium to high-dose glucocorticoid therapy in rheumatic diseases. Ann Rheum Dis 2013; 72: 1905\u201313","DOI":"10.1136\/annrheumdis-2013-203249"},{"key":"10.3238\/arztebl.2017.0197_ref38","doi-asserted-by":"crossref","unstructured":"Krause D, Schleusser B, Herborn G, Rau R: Response to methotrexate treatment is associated with reduced mortality in patients with severe rheumatoid arthritis. Arthritis Rheum 2000; 43: 14\u201321","DOI":"10.1002\/1529-0131(200001)43:1<14::AID-ANR3>3.0.CO;2-7"},{"key":"10.3238\/arztebl.2017.0197_ref39","doi-asserted-by":"crossref","unstructured":"Lutman C, Finocchiaro G, Abate E, Milo M, Morassi P, Sinagra G: Purulent pericarditis in rheumatoid arthritis treated with rituximab and methotrexate. J Cardiovasc Med (Hagerstown) 2014; 15: 880\u20132","DOI":"10.2459\/JCM.0000000000000160"},{"key":"10.3238\/arztebl.2017.0197_ref40","doi-asserted-by":"crossref","unstructured":"Yoshida S, Takeuchi T, Sawaki H, Imai T, Makino S, Hanafusa T: Successful treatment with tocilizumab of pericarditis associated with rheumatoid arthritis. Mod Rheumatol 2014; 24: 677\u201380","DOI":"10.3109\/14397595.2013.874733"},{"key":"10.3238\/arztebl.2017.0197_ref41","unstructured":"Memorandum. Rheumatologische Versorgung von akut und chronisch Rheumakranken in Deutschland. Herausgegeben von der Kommission Versorgung der Deutschen Gesellschaft f\u00fcr Rheumatologie, Juni 2008. www.dgrh.de\/?id=8878 (last accessed on 10 February 2017)."},{"key":"10.3238\/arztebl.2017.0197_ref42","unstructured":"Deutsches Rheumaforschungszentrum (DRFZ) Berlin: Daten der Kerndokumentation 2013. www.dgrh.de\/fileadmin\/media\/Forschung\/Versorgungsforschung\/ErwachsenenKerndok\/Standardpraesentation_2013_extern.pdf (last accessed on 10 February 2017)."},{"key":"10.3238\/arztebl.2017.0197_ref43","doi-asserted-by":"crossref","unstructured":"Sharma TS, Wasko MC, Tang X, et al.: Hydroxychloroquine use is associated with decreased incident cardiovascular events in rheumatoid arthritis patients. J Am Heart Assoc 2016; 5: e002867.","DOI":"10.1161\/JAHA.115.002867"},{"key":"10.3238\/arztebl.2017.0197_ref44","doi-asserted-by":"crossref","unstructured":"Jung H, Bobba R, Su J, et al.: The protective effect of antimalarial drugs on thrombovascular events in systemic lupus erythematosus. Arthritis Rheum 2010; 62: 863\u20138","DOI":"10.1002\/art.27289"},{"key":"10.3238\/arztebl.2017.0197_ref45","unstructured":"Quismorio FP, Beardmore T, Kaufman RL, Mongan ES: IgG rheumatoid factors and anti-nuclear antibodies in rheumatoid vasculitis. Clin Exp Immunol 1983; 52: 333\u201340"},{"key":"10.3238\/arztebl.2017.0197_ref46","doi-asserted-by":"crossref","unstructured":"Badui E, Garcia-Rubi D, Robles E, et al.: Cardiovascular manifestations in systemic lupus erythematosus. Prospective study of 100 patients. Angiology 1985; 36: 431\u201341","DOI":"10.1177\/000331978503600705"},{"key":"10.3238\/arztebl.2017.0197_ref47","doi-asserted-by":"crossref","unstructured":"Crozier IG, Li E, Milne MJ, Nicholls MG: Cardiac involvement in systemic lupus erythematosus detected by echocardiography. Am J Cardiol 1990; 65: 1145\u20138","DOI":"10.1016\/0002-9149(90)90329-Y"},{"key":"10.3238\/arztebl.2017.0197_ref48","doi-asserted-by":"crossref","unstructured":"Hazebroek MR, Kemna MJ, Schalla S, et al.: Prevalence and prognostic relevance of cardiac involvement in ANCA-associated vasculitis: eosinophilic granulomatosis with polyangiitis and granulomatosis with polyangiitis. Int J Cardiol 2015; 199: 170\u20139","DOI":"10.1016\/j.ijcard.2015.06.087"},{"key":"10.3238\/arztebl.2017.0197_ref49","doi-asserted-by":"crossref","unstructured":"Knockaert DC: Cardiac involvement in systemic inflammatory diseases. Eur Heart J 2007; 28: 1797\u2013804","DOI":"10.1093\/eurheartj\/ehm193"},{"key":"10.3238\/arztebl.2017.0197_ref50","doi-asserted-by":"crossref","unstructured":"Gerfaud-Valentin M, S\u00e8ve P, Iwaz J, et al.: Myocarditis in adult-onset still disease. Medicine (Baltimore) 2014; 93: 280\u20139","DOI":"10.1097\/MD.0000000000000112"},{"key":"10.3238\/arztebl.2017.0197_ref51","doi-asserted-by":"crossref","unstructured":"Geri G, Wechsler B, Thi Huong du L, et al.: Spectrum of cardiac lesions in Beh\u00e7et disease: a series of 52 patients and review of the literature. Medicine (Baltimore) 2012; 91: 25\u201334","DOI":"10.1097\/MD.0b013e3182428f49"},{"key":"10.3238\/arztebl.2017.0197_ref52","doi-asserted-by":"crossref","unstructured":"Dib C, Moustafa SE, Mookadam M, Zehr KJ, Michet CJ Jr, Mookadam F: Surgical treatment of the cardiac manifestations of relapsing polychondritis: overview of 33 patients identified through literature review and the Mayo Clinic records. Mayo Clin Proc 2006; 81: 772\u20136","DOI":"10.4065\/81.6.772"},{"key":"10.3238\/arztebl.2017.0197_ref53","doi-asserted-by":"crossref","unstructured":"Mogulkoc N, Burgess MI, Bishop PW: Intracardiac thrombus in Beh\u00e7et\u2018s disease: a systematic review. Chest 2000; 118: 479\u201387","DOI":"10.1378\/chest.118.2.479"},{"key":"10.3238\/arztebl.2017.0197_ref54","doi-asserted-by":"crossref","unstructured":"Lachmann HJ, Goodman HJ, Gilbertson JA, et al.: Natural history and outcome in systemic AA amyloidosis. N Engl J Med 2007; 356: 2361\u201371","DOI":"10.1056\/NEJMoa070265"},{"key":"10.3238\/arztebl.2017.0197_ref55","doi-asserted-by":"crossref","unstructured":"Haroon M, Gallagher P, Heffernan E, FitzGerald O: High prevalence of metabolic syndrome and of insulin resistance in psoriatic arthritis is associated with the severity of underlying disease. J Rheumatol 2014; 41: 1357\u201365","DOI":"10.3899\/jrheum.140021"},{"key":"10.3238\/arztebl.2017.0197_ref56","doi-asserted-by":"crossref","unstructured":"Hollan I, Saatvedt K, Almdahl SM, et al.: Spondyloarthritis: a strong predictor of early coronary artery bypass grafting. Scand J Rheumatol 2008; 37: 18\u201322","DOI":"10.1080\/03009740701716868"},{"key":"10.3238\/arztebl.2017.0197_ref57","doi-asserted-by":"crossref","unstructured":"Tascilar K, Dell\u2018Aniello S, Hudson M, Suissa S: Statins and risk of rheumatoid arthritis: a nested case-control study. Arthritis Rheumatol 2016; 68: 2603\u201311","DOI":"10.1002\/art.39774"},{"key":"10.3238\/arztebl.2017.0197_ref58","doi-asserted-by":"crossref","unstructured":"Schoenfeld SR, Lu L, Rai SK, Seeger JD, Zhang Y, Choi HK: Statin use and mortality in rheumatoid arthritis: a general population-based cohort study. Ann Rheum Dis 2016; 75: 1315\u201320","DOI":"10.1136\/annrheumdis-2015-207714"},{"key":"10.3238\/arztebl.2017.0197_ref59","doi-asserted-by":"crossref","unstructured":"Allenbach Y, Drouot L, Rigolet A, et al.: French Myositis Network. Anti-HMGCR autoantibodies in European patients with autoimmune necrotizing myopathies: inconstant exposure to statin. Medicine (Baltimore) 2014; 93: 150\u20137","DOI":"10.1097\/MD.0000000000000028"},{"key":"10.3238\/arztebl.2017.0197_ref60","doi-asserted-by":"crossref","unstructured":"Mammen AL, Pak K, Williams EK, et al.: Rarity of anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase antibodies in statin users, including those with self-limited musculoskeletal side effects. Arthritis Care Res (Hoboken) 2012; 64: 269\u201372","DOI":"10.1002\/acr.20662"},{"key":"10.3238\/arztebl.2017.0197_ref61","doi-asserted-by":"crossref","unstructured":"McInnes IB, Thompson L, Giles JT, et al.: Effect of interleukin-6 receptor blockade on surrogates of vascular risk in rheumatoid arthritis: MEASURE, a randomised, placebo-controlled study. Ann Rheum Dis 2015; 74: 694\u2013702","DOI":"10.1136\/annrheumdis-2013-204345"},{"key":"10.3238\/arztebl.2017.0197_ref62","doi-asserted-by":"crossref","unstructured":"Thakkar V, Stevens W, Prior D, et al.: The inclusion of N-terminal pro-brain natriuretic peptide in a sensitive screening strategy for systemic sclerosis-related pulmonary arterial hypertension: a cohort study. Arthritis Res Ther 2013; 15: R193.","DOI":"10.1186\/ar4383"},{"key":"10.3238\/arztebl.2017.0197_ref63","doi-asserted-by":"crossref","unstructured":"Luconi N, Risse J, Busato T, et al.: Myocarditis in a young man with adult onset Still\u2018s disease successfully treated with Il-1 blocker. Int J Cardiol 2015; 189: 220\u20132","DOI":"10.1016\/j.ijcard.2015.04.071"},{"key":"10.3238\/arztebl.2017.0197_ref64","doi-asserted-by":"crossref","unstructured":"Conroy RM, Py\u00f6r\u00e4l\u00e4 K, Fitzgerald AP, et al.: SCORE project group. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 2003; 24: 987\u20131003","DOI":"10.1016\/S0195-668X(03)00114-3"}],"container-title":["Deutsches \u00c4rzteblatt international"],"original-title":[],"link":[{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.2017.0197","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,7]],"date-time":"2021-12-07T10:16:38Z","timestamp":1638872198000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.2017.0197"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,24]]},"references-count":64,"URL":"https:\/\/doi.org\/10.3238\/arztebl.2017.0197","relation":{},"ISSN":["1866-0452"],"issn-type":[{"value":"1866-0452","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,24]]}}}